References
- FoleyRNCurtisBMParfreyPSErythropoietin therapy, hemoglobin targets, and quality of life in healthy hemodialysis patients: a randomized trialClin J Am Soc Nephrol20094472673319339412
- TefferiAPruthiRKThe biochemical basis of cobalamin deficiencyMayo Clin Proc19946921811868309270
- StablerSPLindenbaumJAllenRHThe use of homocysteine and other metabolites in the specific diagnosis of vitamin B-12 deficiencyJ Nutr199612641266S1272S8642468
- van GuldenerCWhy is homocysteine elevated in renal failure and what can be expected from homocysteine-lowering?Nephrol Dial Transplant20062151161116616490741
- KhoueiryGWakedAGoldmanMDietary intake in hemodialysis patients does not refect a heart healthy dietJ Ren Nutr201121643844721185740
- HerrmannWSchorrHGeiselJRiegelWHomocysteine, cystathionine, methylmalonic acid and B-vitamins in patients with renal diseaseClin Chem Lab Med200139873974611592444
- MoelbyLKRasmussenKRasmussenHSerum methylmalonic acid in uraemiaScand J Clin Lab Invest19925243513541439520
- MoelbyLRasmussenKRingTNielsenGRelationship between methylmalonic acid and cobalamin in uremiaKidney Int200057126527310620208
- HvasAMJuulSGerdesLUNexoEThe marker of cobalamin deficiency, plasma methylmalonic acid, correlates to plasma creatinineJ Intern Med2000247450751210792566
- JohnsonDWPollockCAMacdougallICErythropoiesis-stimulating agent hyporesponsivenessNephrology (Carlton)200712432133017635745
- ZacheePChewSLDaelemansRLinsRLErythropoietin resistance due to vitamin B12 deficiency. Case report and retrospective analysis of B12 levels after erythropoietin treatmentAm J Nephrol19921231881911415379